Join Tom Lehmann and Petra Jantzer, Accenture's Global Life Sciences Lead, as they cover the highlights of 2025 and look forward to 2026. What's coming next for biopharma? Tune in for the trends and insights that will shape the future.
<p><a href= "https://peterattiamd.com/susandesmondhellmann/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=250428-pod-susandesmondhellmann&utm_content=250428-pod-susandesmondhellmann-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://petera ... Show More